000 01851 a2200493 4500
005 20250516115307.0
264 0 _c20130405
008 201304s 0 0 eng d
022 _a1600-0625
024 7 _a10.1111/exd.12002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReichenbach, Gabi
245 0 0 _aLigand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner.
_h[electronic resource]
260 _bExperimental dermatology
_cOct 2012
300 _a751-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a3' Untranslated Regions
650 0 4 _aBase Sequence
650 0 4 _aCathepsin B
_xantagonists & inhibitors
650 0 4 _aDEAD-box RNA Helicases
_xantagonists & inhibitors
650 0 4 _aEndothelial Cells
_xdrug effects
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aGene Knockdown Techniques
650 0 4 _aHuman Umbilical Vein Endothelial Cells
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aPPAR delta
_xagonists
650 0 4 _aPhenoxyacetates
_xpharmacology
650 0 4 _aProtein Processing, Post-Translational
_xdrug effects
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aRibonuclease III
_xantagonists & inhibitors
650 0 4 _aThiazoles
_xpharmacology
700 1 _aStarzinski-Powitz, Anna
700 1 _aDoll, Monika
700 1 _aHrgovic, Igor
700 1 _aValesky, Eva Maria
700 1 _aKippenberger, Stefan
700 1 _aBernd, August
700 1 _aKaufmann, Roland
700 1 _aMeissner, Markus
773 0 _tExperimental dermatology
_gvol. 21
_gno. 10
_gp. 751-7
856 4 0 _uhttps://doi.org/10.1111/exd.12002
_zAvailable from publisher's website
999 _c22195019
_d22195019